GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/10082

Market Highlights

The Hydroxychloroquine drug is used in the treatment of malaria. Apart from malaria, it is also used for the treatment of rheumatoid arthritis, lupus erythematosus, and recently discovered COVID-19 disease. Hydroxychloroquine is more preferable than chloroquine as it has fewer side effects.

Regional Analysis

Segmentation

The hydroxychloroquine market has been segmented by strength and application

Based on the strength, the hydroxychloroquine market has been segmented into 200mg, 400mg, and others. Among them, 200mg is commonly used to cure arthritis as well as for malaria and recently for COVID-19. 400 mg dosage is commonly used for the treatment of Malaria, Lupus Erythematosus, and Rheumatoid Arthritis once a week for the adults. In addition, the increasing usage of hydroxychloroquine for COVID-19 treatment is driving the growth of the market.

Based on the application, the segment is classified into Coronavirus disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Porphyria cutanea tarda (PCT), Q fever, and others. The malaria segment dominated the global hydroxychloroquine market and held the largest market share in 2019. The hydroxychloroquine is used for the treatment of malaria, which is caused by the mosquito bite. It is a reasonably inexpensive drug and generally sold as over the counter drug in the countries such as India.

Key Players

Some of the key players in hydroxychloroquine market are Zydus Cadila (India), Ipca laboratories (India), Sanofi S.A. (France), Hikma Pharmaceuticals (UK), Novartis International AG (Switzerland), Teva Pharmaceutical, Industries Ltd (Israel), Apotex Corporation (Canada), Mylan N.V. (US), Concordia Healthcare (UK), Amneal Pharmaceuticals, Inc. (US), Taj Pharmaceuticals (India), Sun Pharmaceutical Industries Ltd. (India), Shanghai Pharmaceuticals Holding (China), Hanlim Pharmaceutical (South Korea), Kyung Poong (South Korea), Laurus Labs Limited (India), Covis Pharmaceuticals, Inc. (Switzerland), Lupin Pharmaceutical (India).

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/hydroxychloroquine-market-10082

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.